Stephen Fowler Flatt
CEO at National HealthCare Corporation
Sits on 1 board. Last updated September 27, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: National HealthCare Corporation, 3 years.
National HealthCare Corporation
Director · CEO
Chief executive roles
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 19, 2026 | National HealthCare Corporation | Open-market sale | −1,500 | $237.08 | $355,620 |
| May 20, 2026 | National HealthCare Corporation | Gift | −26 | — | — |
| May 14, 2026 | National HealthCare Corporation | Option exercise | +5,000 | $94.10 | $470,500 |
| May 14, 2026 | National HealthCare Corporation | Option exercise | +1,000 | $90.62 | $90,620 |
| May 14, 2026 | National HealthCare Corporation | Shares withheld for tax | −4,492 | $197.96 | $889,236 |
| Mar 12, 2026 | National HealthCare Corporation | Option exercise | +1,853 | $53.94 | $99,951 |
| Mar 2, 2026 | National HealthCare Corporation | Option exercise | +5,000 | $90.62 | $453,100 |
| Mar 2, 2026 | National HealthCare Corporation | Shares withheld for tax | −3,585 | $171.15 | $613,573 |
| Feb 27, 2026 | National HealthCare Corporation | Grant or award | +3,090 | — | — |
| Dec 29, 2025 | National HealthCare Corporation | Gift | −450 | — | — |
| Dec 12, 2025 | National HealthCare Corporation | Gift | −217 | — | — |
| Dec 12, 2025 | National HealthCare Corporation | Gift | −145 | — | — |
| Nov 25, 2025 | National HealthCare Corporation | Option exercise | +1,853 | $53.94 | $99,951 |
| Nov 21, 2025 | National HealthCare Corporation | Open-market sale | −1,000 | $130.33 | $130,330 |
| Nov 11, 2025 | National HealthCare Corporation | Option exercise | +3,000 | $94.10 | $282,300 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.